Navigation Links
Taking the fear factor out of cancer

It is the second most deadly disease in the Western world and one of the most feared diagnoses a patient can face. Now, a new book penned by a Nottingham academic is aiming to improve our understanding of cancer so we can better deal with its often devastating consequences.

Cancer: A Beginner's Guide is the first book of its kind covering all of the issues related to the disease in a clear and straightforward way, rather than concentrating on just one particular scientific aspect.

The book was the brainchild of author Dr Paul Scotting, of the University of Nottingham's Institute Centre for Genetics and Genomics, who scoured bookshop shelves for such an introductory text on cancer for his medical students before realising that it didn't currently exist.

The book explores the science behind the disease and explores why some of us are more likely to develop it than others and is written with a general audience in mind, meaning it's an accessible read for anyone, from those suffering from cancer to people interested in it as a biological phenomenon.

Dr Scotting said: "Fear comes from a lack of knowledge. If we or someone we know suddenly has this disease and we don't understand the nature of the disease and it is very different to any other disease then it potentially makes their experience much more frightening. My personal feeling is that by understanding something I don't find it so scary and hopefully that's one thing that people will take from this book."

The book is published on November 1 and is due to be unveiled at a special book launch being held at Blackwells Bookshop in The University of Nottingham's Medical School at 5pm on Friday November 5.

Cancer is second only to heart disease as the most common fatal disease, killing one in four people in the West. It will touch all our lives either personally or as bystanders if friends and family are diagnosed with one of its different forms. Yet many of us do not fully understand what cancer really is.

Often, it is portrayed as an alien invader intent on destroying us from within. However, while organisms such as viruses like the superbug Methicillin-Resistant Staphylococcus Aureus (MRSA) feed on us for the good of their own kind, cancer is different: it arises from our own flesh and blood.

The cells of a cancer, which can increase in number to the point when we are eventually unable to fight them off, are our own cells. Cancers normally arise when, due to damage mutations to its genes, just one cell escapes the many controls that make it behave properly.

Dr Scotting's book looks at what goes wrong in rogue cells we call cancer, what causes these defects and how doctors are attempting to remove these wayward cells from our bodies.

Arguing that we are in a new age of understanding that will revolutionise the fight against cancer, it discusses cutting-edge developments and maps out the promising future strategies for its prevention, treatment and cure.

Dr Scotting added: "At the start of the 20th century, cancer had been studied for many hundreds of years but we had almost no understanding of its nature. The German surgeon Paul Kraske said: 'We do not know any more about cancer than our grandfathers did'. I think it is safe to say that we now know a great deal more than our grandfathers, or even our fathers.

"There can be little doubt that the late 20th century saw unprecedented progress in cancer research and understanding and much improved therapies. An even greater rate of improvement is likely in the early decades of the 21st century. I hope that by reading this book people will not only develop a better understanding of what cancer is, why cancer happens and how treatment works but also a confidence that things are now better than ever before and will get better still."


Contact: Emma Thorne
University of Nottingham

Related medicine news :

1. Sexual issues a major concern for cancer patients taking new targeted drugs
2. Taking Blood Pressure Drugs at Bedtime May Boost Effectiveness
3. Texting Taking a Deadly Toll on Roads
4. 1 in 4 stroke patients stop taking prevention medication within 3 months
5. Many Stroke Patients Stop Taking Meds, Study Shows
6. Taking to the Stage to Battle Mental Illness
7. Taking music seriously
8. Taking Public Transit Might Help You Stay Slim
9. Rich Vitamins Proves Taking Vitamins Doesn't Have to be a Pill with New alternaVites
10. Many Docs Dont Mind Taking Gifts From Industry: Study
11. NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs
Post Your Comments:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: